The formulation
The KLOW peptide name holds four ingredients
A short name can hide quite a lot. I find KLOW easier to follow once the four ingredients are named and the claims about mixing them are kept separate.

A blend, rather than a new molecule
KLOW combines GHK-Cu, KPV, BPC-157 and TB-500. A peptide joins amino acids into a short chain; proteins are built from amino acids too. These four substances remain distinct ingredients in the mixture.
Putting them together doesn’t show that they help one another. No controlled study has tested the complete blend against a single ingredient, a smaller combination or a placebo. A placebo is a comparison preparation without the substance being tested.
That’s the part I want beside the appealing explanation. There may be reasons to investigate a combination, but those reasons don’t establish a benefit for someone reading about it.
Who’s who in the mixture
- GHK-Cu
- Glycine, histidine and lysine joined to copper. A review of GHK and skin research gives some background. Skin findings don’t tell us whether the four-part blend grows hair.
- KPV
- Lysine, proline and valine. In cell and mouse bowel experiments, KPV reduced inflammatory signals and bowel inflammation. Those experiments didn’t test a hair treatment in people.
- BPC-157
- A lab-made chain of fifteen amino acids, based on part of a protein identified in human stomach fluid. A study of injured rat Achilles tendons found improved healing measures. It didn’t study human hair.
- TB-500
- A small, lab-made piece of thymosin beta-4, a larger protein. FDA distinguishes the two and found no published human TB-500 study. The larger protein’s results leave the smaller fragment’s effects unanswered.
What a shared label leaves unanswered
If hair growth is your question, the useful test would involve people receiving the actual blend, with a fair comparison. That evidence isn’t available. A related peptide or an animal experiment can explain the interest without answering your question.
The safety of combining the ingredients is also untested. There are open questions about how they behave together, rather than an established combination whose risks can be read from an approved label.
A container’s total contents describe what is inside it. They don’t tell us what amount belongs in a person’s care. The dosage notes separate study amounts from that clinical decision.
I keep the research notes close for the same reason: knowing exactly what a paper tested makes the conclusion easier to judge. The effects page covers the safety gaps and the questions raised by the individual ingredients.